Insider · CIK 0001793112

Schroeder Mark S

Reports to the SEC for 1 company · BURLINGTON, NC

sec.gov

Transactions

Companies

Filings

CIK

0001793112

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-26	LHLABCORP HOLDINGS INC.A Award	EVP, Pres Diagnostics & COO	AAward	+9,304 sh	—	—	15,777.143
2026-03-26	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−4,600 sh	$268.38	−$1.23M	11,177.143
2026-03-26	LHLABCORP HOLDINGS INC.A Award	EVP, Pres Diagnostics & COO	AAward	+2,968 sh	—	—	14,145.143
2026-03-26	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−1,468 sh	$268.38	−$394K	12,677.143
2026-02-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+806 sh	—	—	6,732.143
2026-02-11	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−259 sh	$289.89	−$75.1K	6,473.143
2026-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−806 sh	—	—	2,358
2026-02-09	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−166 sh	$274.01	−$45.5K	5,979.143
2026-02-09	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−53 sh	$274.01	−$14.5K	5,926.143
2026-02-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+517 sh	—	—	5,981.143
2026-02-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+164 sh	—	—	6,145.143
2026-02-07	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−517 sh	—	—	3,328
2026-02-07	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−164 sh	—	—	3,164
2026-02-06	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+743 sh	—	—	5,703.143
2026-02-06	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−239 sh	$277.20	−$66.3K	5,464.143
2026-02-06	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−743 sh	—	—	3,845
2025-03-28	LHLABCORP HOLDINGS INC.S Sale	EVP, Pres Diagnostics & COO	SSale	−2,635 sh	$231.67	−$610K	4,960.143
2025-03-27	LHLABCORP HOLDINGS INC.A Award	EVP, Pres Diagnostics & COO	AAward	+4,840 sh	—	—	9,800.143
2025-03-27	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−2,205 sh	$231.67	−$511K	7,595.143
2025-02-28	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+3,903 sh	$131.43	+$513K	10,299.143
2025-02-28	LHLABCORP HOLDINGS INC.S Sale	EVP, Pres Diagnostics & COO	SSale	−5,339 sh	$249.23	−$1.33M	4,960.143
2025-02-28	LHLABCORP HOLDINGS INC. · Non-qualified Stock OptionsM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−3,903 sh	—	—	0
2025-02-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+473 sh	—	—	6,530.143
2025-02-11	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−134 sh	$245.14	−$32.8K	6,396.143
2025-02-11	LHLABCORP HOLDINGS INC. · Non-qualified Stock OptionsA Award	EVP, Pres Diagnostics & COO	AAward	+7,300 sh	—	—	7,300
2025-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	EVP, Pres Diagnostics & COO	AAward	+2,420 sh	—	—	5,061
2025-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−473 sh	—	—	4,588
2025-02-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+517 sh	—	—	6,086.143
2025-02-07	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−146 sh	$246.27	−$36K	5,940.143
2025-02-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+164 sh	—	—	6,104.143
2025-02-07	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−47 sh	$246.27	−$11.6K	6,057.143
2025-02-07	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−517 sh	—	—	2,805
2025-02-07	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−164 sh	—	—	2,641
2025-02-06	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+743 sh	—	—	5,779.143
2025-02-06	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−210 sh	$247.74	−$52K	5,569.143
2025-02-06	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−743 sh	—	—	3,322
2024-04-01	LHLABCORP HOLDINGS INC.S Sale	EVP, Pres Diagnostics & COO	SSale	−6,477 sh	$217.29	−$1.41M	5,036.143
2024-03-27	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+11.6K sh	—	—	16,592.143
2024-03-27	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−5,079 sh	$216.57	−$1.1M	11,513.143
2024-03-27	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−11.6K sh	—	—	4,065
2024-03-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+2,119 sh	$117.09	+$248K	10,084.143
2024-03-07	LHLABCORP HOLDINGS INC.S Sale	EVP, Pres Diagnostics & COO	SSale	−5,048 sh	$218.45	−$1.1M	5,036.143
2024-03-07	LHLABCORP HOLDINGS INC. · Non-qualified Stock OptionsM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−2,119 sh	—	—	0
2024-02-12	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−126 sh	$227.45	−$28.7K	7,965.143
2024-02-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+472 sh	—	—	8,091.143
2024-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	−472 sh	—	—	15,621
2024-02-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+517 sh	—	—	7,638.143
2024-02-07	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−138 sh	$223.71	−$30.9K	7,500.143
2024-02-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	EVP, Pres Diagnostics & COO	MExercise/Conversion	+163 sh	—	—	7,663.143
2024-02-07	LHLABCORP HOLDINGS INC.F Tax Payment	EVP, Pres Diagnostics & COO	FTax Payment	−44 sh	$223.71	−$9,843.24	7,619.143

Recent filings

Accepted (ET)
Mar 304
Schroeder Mark S0000920148-26-000124
SEC(opens sec.gov)
Feb 134
Schroeder Mark S0000920148-26-000087
SEC(opens sec.gov)
Feb 104
Schroeder Mark S0000920148-26-000029
SEC(opens sec.gov)
Mar 314
Schroeder Mark S0001127602-25-010624
SEC(opens sec.gov)
Mar 44
Schroeder Mark S0001127602-25-007615
SEC(opens sec.gov)

Companies

LABCORP HOLDINGS INC.EVP, Pres Diagnostics & COOLH

Address

531 SOUTH SPRING STREET

BURLINGTON, NC, 27215